Introduction:
Medications are the number one
treatment administered to patients in our hospitals and significantly impact
care and outcomes. CMS has requested all hospitals in the Partnership for
Patients program report on Adverse Drug Events in three areas: opioids,
anticoagulants, and hypoglycemic agents. The Tennessee Pharmacists
Coalition is dedicated to assisting hospitals in improvement for these three
adverse drug event areas as well as in medication reconciliation/readmissions
and antibiotic resistance/antibiotic stewardship.
In an effort
to align both education and reporting on ADEs, THA and the Tennessee Pharmacist
Coalition have identified measures for ADE reporting that will be utilized for
the THA HEN facilities as well as all Tennessee facilities. The THA Board of
Directors has endorsed the following recommendations to foster medication
safety in Tennessee:
- All
hospitals should have a multidisciplinary medication safety team in place.
- All hospitals should
report on the non-mandatory ADE measures identified by the Tennessee
Pharmacists Coalition and reported through the Tennessee Center for Patient
Safety at the Tennessee Hospital Association.
We encourage all Tennessee hospitals
to participate in measuring and sharing your ADE data for establishing a
statewide benchmark for these ADE focus areas. To support this work, we have
developed an ADE educational plan to include sharing of best practices.
Resources:
Medication Safety Webinar Series
Pharmacy Resource Page
Medication Safety Summits
HRET Resources:
Adverse Drug Events (ADE) Change Package
Adverse Drug Events (ADE) Top Ten Checklist
HRET ADE Webinars
AHA Opioid Toolkit